Survey: Patients harmed by anemia drug policy
February 18th, 2008 Posted by: Dr. Dobson
Washington — A new Medicare coverage policy on drug treatment for anemic cancer patients is hurting care, according to a survey of doctors released last month.
Ninety-one percent of oncologists and hematologists reported adverse patient events in the 12 weeks after the July 30 implementation of the national coverage determination on erythropoiesis-stimulating agents. The poll was sponsored by U.S. Oncology, which funds, develops, and helps manage 443 cancer centers in 39 states. It surveyed 307 physicians from Nov. 26, 2007, to Dec. 11, 2007. The organization limited the number of affiliated physicians involved in the poll to 20% of all respondents.
Popularity: unranked [?]
Tags: Survey, Patients, harmed, anemia, policy